Intermittent fasting in the treatment of type 2 diabetes mellitus.
Article Sidebar
Main Article Content
Abstract
The condition of diabetes mellitus (DM) has been characterized as a non-communicable disease (NCD), which is currently the most prevalent morbidity and mortality factor in a common group. Such is the case of diabetes mellitus type 2 (DM2), a silent disease, largely associated with overweight or obesity, forged by a sedentary lifestyle, with hypercaloric eating habits.
Objective: The present research maintains the purpose of determining the effectiveness of IA with the development of a diet scheme of 21 days for the control of the basal glycemia index (IBG) in DM2.
Methodology: It is an experimental correlative research of descriptive type. Where the blood glucose level is evaluated by means of glycated hemoglobin, under informed consent, of those who exercise the treatment of IA. The statistical distinction was made with the nonparametric tests of K-S and Shapiro-Wilk whose purpose was to define the distribution of the variables. The hypotheses were tested by testing the ranges with Wilcoxon signs that measured the means of the indicators of the dependent variable.
Results: Of the 70 patients included in the study, the female group predominated 6 to 1 over the male group suffering from DM2, with an average variability of the superior body mass index (BMI) in women, denoting values of 38.4 and 35.71 respectively. Significant changes in blood glucose indicators could be verified. Glycosylated hemoglobin, weight and waist/hip index; samples were analyzed by blood biochemistry of patients and anthropometric evaluations.
Conclusions: The treatment with IA determines beneficial effects, such as the effect of autophagy, which demonstrated a regularization in blood sugar. However, there is a need for strict monitoring of their application for the side effects of starvation.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
Aksungar B, Sarikaya M, Coskun A, Serteser M, Unsal I. Comparison of intermittent fasting versus caloric restriction in obese subjects: A two year follow-up. Journal of Nutrition, Health and Aging. [Internet] 2017 [Consultado el 18 de mayo del 2022]. 21(6), 681–685.
Álvarez J, Osorio H, Giraldo M, Revisión de los efectos del ayuno intermitente en la salud y recomendaciones para su aplicación. [Internet] 2020 [Consultado el 18 de mayo del 2022] 1(1), 1-32.
American Diabetes Association Faciliting Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes 2020. Diabtes Care [Internet] 2020 [Citado el 22 de mayo del 2022]43 (Suppl,1): S48-S65.
Barbera C, Bargues G, Bisio M, Riera L, Rubio M, Pérez M. El ayuno intermitente: ¿La panacea de la alimentación? Intermittent fasting: the panacea of food?. Actualización en Nutrición. [Internet] 2020 [Cittado el 18 de mayo del 2022]. 21(1), 25-32.
Canicoba M. Aplicaciones clínicas del ayuno intermitente. Rev Nutr Clínica y Metab. [Internet] 2020 [Consultado el 18 de mayo del 2022]. 3(2):87–94.
Pincay C, Segura E. Ayuno intermitente y la resistencia a la insulina: Un análisis al valor predictivo (Bachelor's thesis, Jipijapa. UNESUM). [Internet] 2020 [Consultado el 20 de mayo del 2022] 7(2):75–92.
Instituto Nacional de Estadísticos y Censos [sede web]. Ecuador, [Internet] 2017 [Citado el 24 de mayo de 2022]. Disponible en:https://www.ecuadorencifras.gob.ec/diabetes-segunda-causa-de-muerte-despues-de-las-enfermedades-isquemicas-del-corazon/
Cho Y, Hong N, Kim K, Cho S, Lee M, Lee Y, Lee W. The Effectiveness of Intermittent Fasting to Reduce Body Mass Index and Glucose Metabolism: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, [Internet] 2019 [Citado el 18 de mayo del 2022]. 8(10), 1645.
De Cabo R, Mattson M. Efects od Intermittent Fasting on Health, Aging, and Disease. N Engle J Med. [Internet] 2019 [Consultado el 24 de mayo del 2022]. 381(26), 2541-51.
Oliva J, Peña L, Rodríguez B. Diabetes práctica. Diabetes. [Internet] 2022; [Consultado el 18 de mayo del 2022]. 13(01), 13 - 21.
Doria A, Gatto M, Punzi L. Autophagy in human health and disease. N Engl J Med. [Internet] 2013; 368(19), 1845.
Encuesta Nacional de Salud y Nutrición, Ministerio de Salud Pública [sede web]. Ecuador [citado 8 de junio de 2022]. Disponible en: https://www.salud.gob.ec/encuesta-nacional-de-salud-y-nutricionensanut/
Franco B, Mejía F, Moreno E, Hernández A, Gómez S, Marcial J, Arreguín R. Velázquez A, Ortega C. A high glucose diet induces autophagy in a HLH-30/TFEB-dependent manner and impairs the normal lifespan of C. elegans. Aging (Albany NY). [Internet] 2018 [Consultado el 18 de mayo del 2022]. 10(10), 2657-67.
Fung J. El código de la diabetes: Prevenir y revertir la diabetes tipo-2 de manera natural. 1ª ed. Malaga: Editorial Sirio SA. [Internet] 2018 [Consultado el 18 de mayo del 2022].
Furmli S, Elmasry R, Ramos M, Fung J. Therapeutic use of intermittent fasting for people with type 2 diabetes as an alternative to insulin. [Internet] 2018. [Consultado el 18 de mayo del 2022].
Gamble K, Berry R, Frank S, Young M. Circadian Clock Control of Endocrine Factors. Nat Rev Endocrinol. [Internet] 2014 [Consultado el 18 de mayo del 2022]. 10(8), 466-75.
Gibbs M, Harrington D, Sterkey S, Williams P, Hampton S. Diurnal postprandial responses to low and high glycaemic index mixed meals. Clin Nutr. [Internet] 2014 [Consultado el 18 de mayo del 2022]. 33(5), 889-94.
González A, Valdez J, Acevedo O, Ramírez E, Ponce R. Utilidad de la hemoglobina glucosilada como indicador de la función renal en adultos mayores diabéticos y no diabéticos. Rev Médica Paz. [Internet] 2015 [Consultado el 18 de mayo del 2022]. 21(2),18-24.
Lertora J, Peralta C. Hemoglobina glicosilada como indicador de complicaciones al momento del diagnóstico de diabetes mellitus tipo 2 en pacientes mayores de 45 años en el Hospital General Guasmo Sur del 2018 al 2019. [Internet] 2021. [Consultado el 18 de mayo del 2022].
Metcalf A, Kyle C, Kenealy T, Jackson T. HbA1c in relation to incident diabetes and diabetes-related complications in non-diabetic adults at baseline. J Diabetes Complications. mayo de 2017 [Internet]; [Consultado el 18 de mayo del 2022]. 31(5), 814-23
Organización Mundial de la Salud [sede web]. Ginebra, 2016. [citado el 8 de junio del 2022] disponible en: https://apps.who.int/iris/bitstream/handle/10665/254649/9789243565255-spa.pdf
Phillips M. Fasting as a Therapy in Neurological Disease Nutrientes. [Internet] 2019 [Consultado el 18 de mayo del 2022]. 11(10), 2501.
Pincay C, Segura E. Ayuno Intermitente y Resistencia a la Insulina: Un análisis al valor predictivo. [Internet] 2020 [Consultado el 18 de mayo del 2022].
Poillet L, White E. Role of tumor and host autophagy in cancer metabolism. Genes Dev. [Internet] 2019 [Consultado el 18 de mayo del 2022]. 33(11-12), 610-9.
Potter D, Cade E, Grant J, Hardie J. Nutrition and the Circadian System. BrJ Nutr. [Internet] 2016 [Consultado el 20 de mayo del 2022]. 116(3), 434-42.
Potter D, Skene J, Arendt J, Cade E, Grant J, Hardie J. Gircadian Rhythm and Sleep Disruption; Causes, Metabolic Consequences, and Countermeasures. Endocr Rev. [Internet] 2016 [Consultado el 22 de mayo del 2022]. 37(6), 574-608.
Rabanal Y, Otten E, Korolchuk V. mTORC1 as the main gateway to autophagy. Essays Biochem. [Internet] 2017 [Consultado el 14 de mayo del 2022]. 61(6), 565-84.
Sánchez B, Santillano D, Espinoza C, Zepeda P, Martinez G, López A. Effect of intermittent energy restriction on weight loss compared to continuous energy restriction in overweight and obese adults: A systematic review. Rev Esp Nutr Humana y Diet. [Internet] 2021 [Consultado el 1 de junio del 2022]. 25(3), 303–15.
Singh R, Cuervo M. Autophagy in the cellular energetic balance. Cell Metab [Internet] 2011; [Consultado el 18 de mayo del 2022]. 13(5), 495-504.
Papamichou D, Panagiotakos D, Itsiopoulos C. Dietary patterns andmanagement of type 2 diabetes: A systematic review of randomisedclinical trials. Nutrition, Metabolism & Cardiovascular Diseases. [Internet] 2019 [Consultado el 28 de mayo del 2022]. 29(6), 531-43.
Velázquez M, González S, Díaz A, García M, Lorelei Á, Ayala S, Jesús A, Coronel C. Autofagia en las células beta pancreáticas y su papel en la diabetes mellitus tipo 2. Revista de la Facultad de Medicina (México). [Internet] 2021 [Consultado el 3 de junio del 2022]. 64(6), 9-25
